2 assets in Hemangioblastoma

Therapeutic assets addressing Hemangioblastoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Belzutifan Hemangioblastoma	José Claudio Casali da Rocha	P2	CCC (53)
Nivolumab Hemangioblastoma	Instituto do Cancer do Estado de São Paulo	P2	CCC (53)